Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-nitro-8-hydroxyquinoline
2. 5-nitroquinolin-8-ol
3. 5-nitrox
4. 5-nok
5. Cysto-saar Plus
6. Nibiol
7. Nitroxoline Monofluoride
8. Nitroxoline, Potassium Salt
1. 5-nitroquinolin-8-ol
2. 8-hydroxy-5-nitroquinoline
3. 4008-48-4
4. 5-nitro-8-hydroxyquinoline
5. 5-nitro-8-quinolinol
6. Nitroxolin
7. 5-nitrox
8. Noxibiol
9. Nibiol
10. Noxin
11. 8-quinolinol, 5-nitro-
12. 5-nitroxine
13. 5-nitroks
14. 5-nok
15. 5-nitro-8-oxyquinoline
16. 5nok
17. Nitroxolinum
18. 5-nitro-8-oxychinoline
19. Nitroxolina
20. Nitroxolinum [inn-latin]
21. Nitroxolina [inn-spanish]
22. A-82
23. Bas 58
24. Nsc 74947
25. Mls000069750
26. Nsc-74947
27. Smr000059036
28. Galinok
29. Chebi:67121
30. Isinok
31. Nicene Forte
32. Nitroxoline (inn)
33. A8m33244m6
34. Ncgc00160664-01
35. Nitroxoline [inn]
36. Uro-coli
37. Dsstox_cid_26284
38. Dsstox_rid_81510
39. Dsstox_gsid_46284
40. Cas-4008-48-4
41. Nitroxoline [inn:ban:dcf]
42. Einecs 223-662-4
43. Brn 0166146
44. Nitroxlina
45. Unii-a8m33244m6
46. Nitroxoline (tn)
47. Hnq
48. Nitrohydroxyquinoline
49. Mfcd00006791
50. 3ai8
51. 5-nitroquinoline-8-ol
52. Opera_id_204
53. 5-nitro-quinolin-8-ol
54. Nitroxoline [mi]
55. 5-nitro-8hydroxyquinoline
56. Quinolin-8-ol, 5-nitro-
57. Nitroxoline [mart.]
58. Oprea1_594857
59. 8-hydroxy-5-nitro-chinoline
60. Nitroxoline [who-dd]
61. 5-21-03-00297 (beilstein Handbook Reference)
62. Cid_19910
63. Mls001148594
64. Schembl151248
65. Regid_for_cid_19910
66. 5-nitroquinolin-8-ol, 96%
67. Wln: T66 Bnj Gnw Jq
68. Chembl1454910
69. Dtxsid4046284
70. Bdbm64987
71. Hms2230i14
72. Hms3264c05
73. Hms3374d08
74. Kuc105356n
75. Pharmakon1600-01506173
76. 8-hydroxy-5-nitroquinoline, 96%
77. Amy23308
78. Hy-b1159
79. Nsc74947
80. Tox21_111969
81. Ksc-8-140
82. Nsc760393
83. S4591
84. Stk099582
85. Zinc15831592
86. Akos001053242
87. Tox21_111969_1
88. Ac-7828
89. Ccg-213981
90. Cs-4761
91. Db01422
92. Nsc-760393
93. Ps-5547
94. Ncgc00160664-03
95. Db-049530
96. A6696
97. Ft-0621541
98. H0805
99. 08n484
100. D07245
101. 5-nitro-8-quinolinol
102. 5-nitro-8-hydroxyquinoline
103. Ab00572598_14
104. Ag-205/04556035
105. Q304570
106. Sr-01000721863
107. Sr-01000721863-4
108. W-106391
109. Z56922155
| Molecular Weight | 190.16 g/mol |
|---|---|
| Molecular Formula | C9H6N2O3 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 190.03784206 g/mol |
| Monoisotopic Mass | 190.03784206 g/mol |
| Topological Polar Surface Area | 78.9 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 229 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Nitroxoline is an antibiotic agent.
Anti-Infective Agents, Urinary
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01X - Other antibacterials
J01XX - Other antibacterials
J01XX07 - Nitroxoline
This drug may also have antitumor activity by inhibition of type 2 methionine aminopeptidase (MetAP2) protein which is involved in angiogenesis. Its antibacterial activity may stem from the metal ion complexation vital for bacterial growth.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Nitroxoline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitroxoline, including repackagers and relabelers. The FDA regulates Nitroxoline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitroxoline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nitroxoline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nitroxoline supplier is an individual or a company that provides Nitroxoline active pharmaceutical ingredient (API) or Nitroxoline finished formulations upon request. The Nitroxoline suppliers may include Nitroxoline API manufacturers, exporters, distributors and traders.
click here to find a list of Nitroxoline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nitroxoline written confirmation (Nitroxoline WC) is an official document issued by a regulatory agency to a Nitroxoline manufacturer, verifying that the manufacturing facility of a Nitroxoline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nitroxoline APIs or Nitroxoline finished pharmaceutical products to another nation, regulatory agencies frequently require a Nitroxoline WC (written confirmation) as part of the regulatory process.
click here to find a list of Nitroxoline suppliers with Written Confirmation (WC) on PharmaCompass.
Nitroxoline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nitroxoline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nitroxoline GMP manufacturer or Nitroxoline GMP API supplier for your needs.
A Nitroxoline CoA (Certificate of Analysis) is a formal document that attests to Nitroxoline's compliance with Nitroxoline specifications and serves as a tool for batch-level quality control.
Nitroxoline CoA mostly includes findings from lab analyses of a specific batch. For each Nitroxoline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nitroxoline may be tested according to a variety of international standards, such as European Pharmacopoeia (Nitroxoline EP), Nitroxoline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nitroxoline USP).
LOOKING FOR A SUPPLIER?
